Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Courtney Campbell(Washington University in St. Louis), Nitasha Sarswat(NorthShore University HealthSystem), D. Eric Steidley(WinnMed), Sanjiv J. Shah(Northwestern University), Olga Azevedo(British Heart Foundation), Eun‐Seok Jeon, Nowell M. Fine(University of Calgary), Ronald Witteles(Alnylam Pharmaceuticals (United States)), Claudio Rapezzi(University of Ferrara), Dianna Quan(University of Michigan), Jonas Wixner(Umeå University), Hans Nienhuis(University Medical Center Groningen), Hartmut Schmidt(Université Paris-Sud), Márcia Waddington‐Cruz(Université Paris-Sud), Burkhard Gess(RWTH Aachen University), Hector Ventura(Ochsner Health System), José González‐Costello(British Heart Foundation), Mazen Hanna(Cleveland Clinic), Saša Živković(University of Pittsburgh), Christopher R. Mueller(Queen's University), José Tallaj(University of Alabama at Birmingham Hospital), Johan Van Cleemput, James M. Tauras(Cornell University), Doug Chapman(Pfizer (United States)), Yoshiki Sekijima(Shinshu University), Violaine Planté‐Bordeneuve(Université Paris-Est Créteil), David Slosky(Jisc), Daniel J. Lenihan(Saint Francis Medical Center), Samantha LoRusso(Ohio University), Michele Emdin(Scuola Superiore Sant'Anna), Mathew S. Maurer(Alnylam Pharmaceuticals (United States)), Jeffrey Ralph, Pablo García‐Pavía(Universidad Francisco de Vitoria), Daniel Jacoby(Baim Institute for Clinical Research), Scott L. Hummel(VA Ann Arbor Healthcare System), Arnt V. Kristen(Heidelberg University), Brian Drachman(Penn Presbyterian Medical Center), William Cotts, Stephen S. Gottlieb(University of Maryland, Baltimore), Martha Grogan(Mayo Clinic in Arizona), Olivier Lairez(Hôpital Rangueil), Leslie Amass(Pfizer (United States)), Michael Polydefkis(Université Paris-Sud), Roberto Fernández‐Torrón(Biogipuzkoa Health Research Institute), Calogero Lino Cirami(Azienda Ospedaliero-Universitaria Careggi), José Nativi-Nicolau(Jacksonville College), Angela Dispenzieri(Mayo Clinic), Srinivas Murali(Allegheny General Hospital), H. Moelgaard(Karolinska University Hospital)
Cited by 51
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k